Trump’s Doj sends letters to medical journals.
Funding of Bloomberg
In Trump’s administration, Even medical academic journals are examined to wake up very much.
On April 14, the medical journal evaluated by peer BOSOMwhich focuses on respiratory diseases and sleeping medicine, received a letter from Edward Martin, the younger, the US Attorney General on the Columbia region, exploring whether the publication is “party” and asking a series of questions about the acceptance of “competitors”.
THE The letter was posted to Bluesky And in x by Dr. Eric Reinhart, a social psychiatrist based in Chicago on Thursday. The American College of Thoracic Doctors, which publishes BOSOM, confirmed to Tower By email on Friday afternoon that she had received the letter, which said she was published online without her knowledge.
“Legal adviser is currently considering the DOJ request,” spokesman Laura Dimasi said Tower by email. “We have no further comments on this issue right now.”
Commercial publication Medpage today reported on Friday that at least three magazines had received the letters. Did not recognize the other two posts.
The letter published in full online addressed Bosom Publisher Dr. Peter Mazzone, Pulmonologist at Cleveland Clinic. In this, Martin wrote that “more and more magazines and publications such as the Chest Journal admit that they are compatriots in various scientific discussions” and asked to answer five questions by May 2.
Bosom Dimasi pointed out the 90 -year -old publication statement This noted that he kept the ethical guidelines for the scientific edition and that he “published numerous articles that were discoveries in scientific research and clinical therapy, promoting medical profession and improving the health and prosperity of patients worldwide”.
Tower reached seven other medical journals by email, including top posts such as Price and Science. No one responded except for the New England Medicine newspaperwho said he had not received a letter from Doj.
DOJ did not immediately respond to a request for comments.
More than Forbes
